Sagimet Biosciences, Inc. Class A(SGMT)
$11.41+0.52 (+4.78%)
SGMT
Sagimet Biosciences, Inc. Class A earnings date
$11.41
At close:+0.52 (+4.78%)
Want to see SGMT full AI Analyst Report?
Sagimet Biosciences, Inc. Class A (SGMT) Q2 2023 Earnings Report
1,726 Followers
SGMT Q2 2023 EPS Results
- Actual EPS
- -$35.80
- Consensus EPS
- -$0.50
- Beat/Miss
- Missed by -$35.30
- One Year Ago EPS
- ―
SGMT Q2 2023 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/21/2023
- Time
- After Close
- Conference Call
- Monday, August 21, 2023
SGMT Upcoming Earnings
Sagimet Biosciences, Inc. Class A's next earnings date is estimated for March 17, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
SGMT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 17, 2027 | 2026 (Q4) | ―- | -0.29 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.260.31 | -0.4 | 177.50% (+0.71) | |
| Aug 11, 2026 | 2026 (Q2) | -0.25-0.26 | -0.32 | 18.75% (+0.06) | |
| May 12, 2026 | 2026 (Q1) | -0.37-0.33 | -0.56 | 41.07% (+0.23) | |
| Mar 11, 2026 | 2025 (Q4) | -0.43-0.29 | -0.5 | 42.00% (+0.21) | |
| Nov 13, 2025 | 2025 (Q3) | -0.39-0.40 | -0.45 | 11.11% (+0.05) | |
| Aug 13, 2025 | 2025 (Q2) | -0.51-0.32 | -0.25 | -28.00% (-0.07) | |
| May 08, 2025 | 2025 (Q1) | -0.67-0.56 | -0.23 | -143.48% (-0.33) | |
| Mar 12, 2025 | 2024 (Q4) | -0.62-0.50 | -0.36 | -38.89% (-0.14) | |
| Nov 14, 2024 | 2024 (Q3) | -0.39-0.45 | -0.35 | -28.57% (-0.10) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
